Cite
MLA Citation
Roger Li et al.. “MP54-04 A PHASE II STUDY OF CHECK POINT INHIBITOR, DURVALUMAB (MEDI4736) FOR BACILLUS CALMETTE-GUERIN UNRESPONSIVE CARCINOMA IN SITU OF THE BLADDER.” Journal of urology, vol. 207, n.d., pp. e927–. http://access.bl.uk/ark:/81055/vdc_100153739050.0x00003e